Relevance of Cytochrome P450 Polymorphisms in the Treatment of Helicobacter pylori Infection and Gastroesophageal Reflux Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6204|4|1|47-56

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.4, Iss.1, 2006-03, pp. : 47-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Gastroesophageal Reflux Disease*

By Pettit Michael  

Pharmacy World and Science, Vol. 27, Iss. 6, 2005-12 ,pp. : 432-435

Springer Publishing Company

Access to resources Recommend Favorite

Cytochrome P450 polymorphisms and drug-induced interstitial lung disease

By Schwaiblmair Martin   Behr Werner   Foerg Wolfgang   Berghaus Thomas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1547-1560

Informa Healthcare

Access to resources Recommend Favorite

CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor

By Furuta Takahisa   Sugimoto Mitsushige   Shirai Naohito   Ishizaki Takashi  

Pharmacogenomics, Vol. 8, Iss. 9, 2007-09 ,pp. : 1199-1210

Future Medicine

Access to resources Recommend Favorite

Strategy for the Treatment of Helicobacter pylori Infection

By  

Current Pharmaceutical Design, Vol. 20, Iss. 28, 2014-08 ,pp. : 4489-4500

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Helicobacter pylori Infection in Children

By  

Current Pharmaceutical Design, Vol. 6, Iss. 15, 2000-10 ,pp. : 1531-1536

Bentham Science Publishers

Access to resources Recommend Favorite